-
1
-
-
78449275458
-
Proposal for a revised taxonomy of the family Filoviridae: Classification, names of taxa and viruses, and virus abbreviations
-
Kuhn JH, Becker S, Ebihara H, et al. Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Arch. Virol. 155(12), 2083-2103 (2010
-
(2010)
Arch. Virol
, vol.155
, Issue.12
, pp. 2083-2103
-
-
Kuhn, J.H.1
Becker, S.2
Ebihara, H.3
-
2
-
-
34249289035
-
Filovirus replication and transcription
-
Mühlberger E. Filovirus replication and transcription. Future Virol. 2(2), 205-215 (2007
-
(2007)
Future Virol
, vol.2
, Issue.2
, pp. 205-215
-
-
Mühlberger, E.1
-
3
-
-
84918791874
-
Ebola virus outbreak 2014: Clinical review for emergency physicians
-
Meyers L, Frawley T, Goss S, Kang C. Ebola virus outbreak 2014: clinical review for emergency physicians. Ann. Emerg. Med. 65(1), 101-108 (2015
-
(2015)
Ann. Emerg. Med
, vol.65
, Issue.1
, pp. 101-108
-
-
Meyers, L.1
Frawley, T.2
Goss, S.3
Kang, C.4
-
4
-
-
84949460157
-
Molecular evidence of sexual transmission of Ebola virus
-
Mate SE, Kugelman JR, Nyenswah TG, et al. Molecular evidence of sexual transmission of Ebola virus. N. Engl. J. Med. 373(25), 2448-2454 (2015
-
(2015)
N. Engl. J. Med
, vol.373
, Issue.25
, pp. 2448-2454
-
-
Mate, S.E.1
Kugelman, J.R.2
Nyenswah, T.G.3
-
5
-
-
0018938185
-
Ebola hemorrhagic fever: Tandala Zaire 1977-1978
-
Heymann DL, Weisfeld JS, Webb PA, Johnson KM, Cairns T, Berquist H. Ebola hemorrhagic fever: Tandala, Zaire, 1977-1978. J. Infect. Dis. 142(3), 372-376 (1980
-
(1980)
J. Infect. Dis
, vol.142
, Issue.3
, pp. 372-376
-
-
Heymann, D.L.1
Weisfeld, J.S.2
Webb, P.A.3
Johnson, K.M.4
Cairns, T.5
Berquist, H.6
-
6
-
-
84865398678
-
Cutaneous manifestations of filovirus infections
-
Nkoghe D, Leroy EM, Toung-Mve M, Gonzalez JP. Cutaneous manifestations of filovirus infections. Int. J. Dermatol. 51(9), 1037-1043 (2012
-
(2012)
Int. J. Dermatol
, vol.51
, Issue.9
, pp. 1037-1043
-
-
Nkoghe, D.1
Leroy, E.M.2
Toung-Mve, M.3
Gonzalez, J.P.4
-
7
-
-
0032993303
-
Clinical, virologic, and immunologic follow-up of convalescent ebola hemorrhagic fever patients and their household contacts, kikwit, democratic republic of the congo commission de lutte contre les epidémies à kikwit
-
Rowe AK, Bertolli J, Khan AS, et al. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit. J. Infect. Dis. 179(Suppl. 1), S28-S35 (1999
-
(1999)
J. Infect. Dis
, vol.179
, pp. S28-S35
-
-
Rowe, A.K.1
Bertolli, J.2
Khan, A.S.3
-
8
-
-
84974717508
-
Filoviridae: Marburg and ebola viruses
-
Fields Virology. Knipe DM, Howley PM, Cohen JI, G DE, Lamb RA, Martin MA, Racaniello VR RB (Eds Williams & Wilkins, PA, USA
-
Feldmann H, Sanchez A, Geisbert TW. Filoviridae: Marburg and Ebola viruses. In: Fields Virology. Knipe DM, Howley PM, Cohen JI, G DE, Lamb RA, Martin MA, Racaniello VR RB (Eds). Lippincott Williams & Wilkins, PA, USA, 1410-1448 (2013
-
(2013)
Lippincott
, pp. 1410-1448
-
-
Feldmann, H.1
Sanchez, A.2
Geisbert, T.W.3
-
9
-
-
0017772897
-
Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire
-
Johnson KM, Lange JV, Webb PA, Murphy FA. Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire. Lancet 1(8011), 569-571 (1977
-
(1977)
Lancet
, vol.1
, Issue.8011
, pp. 569-571
-
-
Johnson, K.M.1
Lange, J.V.2
Webb, P.A.3
Murphy, F.A.4
-
10
-
-
0033036025
-
Ebola outbreak in Kikwit Democratic Republic of the Congo: Discovery and control measures
-
Muyembe-Tamfum JJ, Kipasa M, Kiyungu C, Colebunders R. Ebola outbreak in Kikwit, Democratic Republic of the Congo: discovery and control measures. J. Infect. Dis. 179(Suppl. 1), S259-S262 (1999
-
(1999)
J. Infect. Dis
, vol.179
, pp. S259-S262
-
-
Muyembe-Tamfum, J.J.1
Kipasa, M.2
Kiyungu, C.3
Colebunders, R.4
-
11
-
-
0036885737
-
An outbreak of ebola in Uganda
-
Okware SI, Omaswa FG, Zaramba S, et al. An outbreak of Ebola in Uganda. Trop. Med. Int. Health. 7(12), 1068-1075 (2002
-
(2002)
Trop. Med. Int. Health
, vol.7
, Issue.12
, pp. 1068-1075
-
-
Okware, S.I.1
Omaswa, F.G.2
Zaramba, S.3
-
12
-
-
84964363505
-
-
WHO 2016
-
WHO. Ebola Situation Report - 16 March 2016 (2016). http://apps.who.int/Ebola/current-situation/Ebola-situation-report-9-december-2015
-
(2016)
Ebola Situation Report - 16 March
-
-
-
13
-
-
0033062193
-
Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients
-
International Scientific and Technical Committee
-
Mupapa K, Massamba M, Kibadi K, et al. Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee. J. Infect. Dis. 179(Suppl. 1), S18-S23 (1999
-
(1999)
J. Infect. Dis
, vol.179
, pp. S18-S23
-
-
Mupapa, K.1
Massamba, M.2
Kibadi, K.3
-
14
-
-
84960470974
-
Progression of Ebola therapeutics during the 2014-2015 outbreak
-
Mendoza EJ, Qiu X, Kobinger GP. Progression of Ebola therapeutics during the 2014-2015 outbreak. Trends Mol. Med. 22(2), 164-173 (2016
-
(2016)
Trends Mol. Med
, vol.22
, Issue.2
, pp. 164-173
-
-
Mendoza, E.J.1
Qiu, X.2
Kobinger, G.P.3
-
15
-
-
34547937985
-
The clinical uses of human serums preserved by the lyophile process
-
McGuinness AC, Stokes J, Mudd S. The clinical uses of human serums preserved by the lyophile process. J. Clin. Invest. 16(2), 185-196 (1937
-
(1937)
J. Clin. Invest
, vol.16
, Issue.2
, pp. 185-196
-
-
McGuinness, A.C.1
Stokes, J.2
Mudd, S.3
-
16
-
-
34249045924
-
Value of convalescent blood and serum in treatment of influenzal pneumonia
-
Stoll HF. Value of convalescent blood and serum in treatment of influenzal pneumonia. JAMA 73(7), 478 (1919
-
(1919)
JAMA
, vol.73
, Issue.7
, pp. 478
-
-
Stoll, H.F.1
-
17
-
-
0036720105
-
A history of immune globulin therapy, from the Harvard crash program to monoclonal antibodies
-
Berger M. A history of immune globulin therapy, from the Harvard crash program to monoclonal antibodies. Curr. Allergy Asthma Rep. 2(5), 368-378 (2002
-
(2002)
Curr. Allergy Asthma Rep
, vol.2
, Issue.5
, pp. 368-378
-
-
Berger, M.1
-
18
-
-
84922676086
-
Treatment of typhoid fever with convalescent whole blood
-
Dewar HA. Treatment of typhoid fever with convalescent whole blood. J. R. Army Med. Corps 86, 249-253 (1946
-
(1946)
J. R. Army Med. Corps
, vol.86
, pp. 249-253
-
-
Dewar, H.A.1
-
19
-
-
0017737552
-
A case of Ebola virus infection
-
Emond RT, Evans B, Bowen ET, Lloyd G. A case of Ebola virus infection. Br. Med. J. 2(6086), 541-544 (1977
-
(1977)
Br. Med. J
, vol.2
, Issue.6086
, pp. 541-544
-
-
Emond, R.T.1
Evans, B.2
Bowen, E.T.3
Lloyd, G.4
-
20
-
-
82555170327
-
From whole blood to component therapy: The economic, supply/demand need for implementation of component therapy in sub-Saharan Africa
-
Erhabor O, Adias TC. From whole blood to component therapy: the economic, supply/demand need for implementation of component therapy in sub-Saharan Africa. Transfus. Clin. Biol. 18(5-6), 516-526 (2011
-
(2011)
Transfus. Clin. Biol
, vol.18
, Issue.5-6
, pp. 516-526
-
-
Erhabor, O.1
Adias, T.C.2
-
21
-
-
84943182977
-
Acute respiratory distress syndrome after convalescent plasma use: Treatment of a patient with Ebola virus disease contracted in Madrid
-
Mora-Rillo M, Arsuaga M, Ramírez-Olivencia G, et al. Acute respiratory distress syndrome after convalescent plasma use: treatment of a patient with Ebola virus disease contracted in Madrid, Spain. Lancet Respir. Med. 3(7), 554-562 (2015
-
(2015)
Spain. Lancet Respir. Med
, vol.3
, Issue.7
, pp. 554-562
-
-
Mora-Rillo, M.1
Arsuaga, M.2
Ramírez-Olivencia, G.3
-
22
-
-
84959017828
-
Clinical management of Ebola virus disease in the United States and Europe
-
Uyeki TM, Mehta AK, Davey RT, et al. Clinical management of Ebola virus disease in the United States and Europe. N. Engl. J. Med. 374(7), 636-646 (2016
-
(2016)
N. Engl. J. Med
, vol.374
, Issue.7
, pp. 636-646
-
-
Uyeki, T.M.1
Mehta, A.K.2
Davey, R.T.3
-
24
-
-
84954349613
-
The use of Ebola convalescent plasma to treat Ebola virus disease in resource-constrained settings: A perspective from the field
-
Van Griensven J, De Weiggheleire A, Delamou A, et al. The use of Ebola convalescent plasma to treat Ebola virus disease in resource-constrained settings: a perspective from the field. Clin. Infect. Dis. 52(1), 69-74 (2015
-
(2015)
Clin. Infect. Dis
, vol.52
, Issue.1
, pp. 69-74
-
-
Van Griensven, J.1
De Weiggheleire, A.2
Delamou, A.3
-
26
-
-
84954049384
-
Evaluation of convalescent plasma for Ebola virus disease in Guinea
-
Van Griensven J, Edwards T, de Lamballerie X, et al. Evaluation of convalescent plasma for Ebola virus disease in Guinea. N. Engl. J. Med. 374(1), 33-42 (2016
-
(2016)
N. Engl. J. Med
, vol.374
, Issue.1
, pp. 33-42
-
-
Van Griensven, J.1
Edwards, T.2
De Lamballerie, X.3
-
27
-
-
84930246161
-
Backs against the wall: Novel and existing strategies used during the 2014-2015 Ebola virus outbreak
-
Wong G, Kobinger GP. Backs against the wall: novel and existing strategies used during the 2014-2015 Ebola virus outbreak. Clin. Microbiol. Rev. 28(3), 593-601 (2015
-
(2015)
Clin. Microbiol. Rev
, vol.28
, Issue.3
, pp. 593-601
-
-
Wong, G.1
Kobinger, G.P.2
-
28
-
-
85002487975
-
Ebola-Tx Consortium Efficacy of convalescent plasma in relation to dose of Ebola virus antibodies
-
Van Griensven J, Edwards T, Baize S, Ebola-Tx Consortium. Efficacy of convalescent plasma in relation to dose of Ebola virus antibodies. N. Engl. J. Med. 375(23), 2307-2309 (2016
-
(2016)
N. Engl. J. Med
, vol.375
, Issue.23
, pp. 2307-2309
-
-
Van Griensven, J.1
Edwards, T.2
Baize, S.3
-
29
-
-
79952943828
-
Fundamentals of vaccine immunology
-
Clem AS. Fundamentals of vaccine immunology. J. Glob. Infect. Dis. 3(1), 73-78 (2011
-
(2011)
J. Glob. Infect. Dis
, vol.3
, Issue.1
, pp. 73-78
-
-
Clem, A.S.1
-
30
-
-
84975516479
-
Ebola-Tx Consortiumi Convalescent plasma for Ebola virus disease
-
Van Griensven J, Edwards T, Gallian P, Ebola-Tx Consortium. Convalescent plasma for Ebola virus disease. N. Engl. J. Med. 374(25), 2500 (2016
-
(2016)
N. Engl. J. Med
, vol.374
, Issue.25
, pp. 2500
-
-
Van Griensven, J.1
Edwards, T.2
Gallian, P.3
-
31
-
-
38449092660
-
Ebola hemorrhagic fever: Evaluation of passive immunotherapy in nonhuman primates
-
Jahrling PB, Geisbert JB, Swearengen JR, Larsen T, Geisbert TW. Ebola hemorrhagic fever: evaluation of passive immunotherapy in nonhuman primates. J. Infect. Dis. 196(Suppl. 2), S400-S403 (2007
-
(2007)
J. Infect. Dis
, vol.196
, pp. S400-S403
-
-
Jahrling, P.B.1
Geisbert, J.B.2
Swearengen, J.R.3
Larsen, T.4
Geisbert, T.W.5
-
32
-
-
84859462127
-
Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease
-
Dye JM, Herbert AS, Kuehne AI, et al. Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease. Proc. Natl Acad. Sci. USA 109(13), 5034-5039 (2012
-
(2012)
Proc. Natl Acad. Sci. USA
, vol.109
, Issue.13
, pp. 5034-5039
-
-
Dye, J.M.1
Herbert, A.S.2
Kuehne, A.I.3
-
33
-
-
84922806645
-
Molecular characterization of the monoclonal antibodies composing ZMAb: A protective cocktail against Ebola virus
-
Audet J, Wong G, Wang H, et al. Molecular characterization of the monoclonal antibodies composing ZMAb: a protective cocktail against Ebola virus. Sci. Rep. 4, 6881 (2014
-
(2014)
Sci. Rep
, vol.4
, pp. 6881
-
-
Audet, J.1
Wong, G.2
Wang, H.3
-
34
-
-
84944511031
-
Filovirus pathogenesis and immune evasion: Insights from Ebola virus and Marburg virus
-
Messaoudi I, Amarasinghe GK, Basler CF. Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus. Nat. Rev. Microbiol. 13(11), 663-676 (2015
-
(2015)
Nat. Rev. Microbiol
, vol.13
, Issue.11
, pp. 663-676
-
-
Messaoudi, I.1
Amarasinghe, G.K.2
Basler, C.F.3
-
35
-
-
84862525229
-
Successful treatment of Ebola virus-infected cynomolgus macaques with monoclonal antibodies
-
138ra81
-
Qiu X, Audet J, Wong G, et al. Successful treatment of Ebola virus-infected cynomolgus macaques with monoclonal antibodies. Sci. Transl. Med. 4(138), 138ra81 (2012
-
(2012)
Sci. Transl. Med
, vol.4
, Issue.138
-
-
Qiu, X.1
Audet, J.2
Wong, G.3
-
36
-
-
84945217199
-
Mechanism of binding to Ebola virus glycoprotein by the ZMapp ZMAb and MB-003 cocktail antibodies
-
Davidson E, Bryan C, Fong RH, et al. Mechanism of binding to Ebola virus glycoprotein by the ZMapp, ZMAb, and MB-003 cocktail antibodies. J. Virol. 89(21), 10982-10992 (2015
-
(2015)
J. Virol
, vol.89
, Issue.21
, pp. 10982-10992
-
-
Davidson, E.1
Bryan, C.2
Fong, R.H.3
-
37
-
-
84886410412
-
MAbs and Ad-vectored IFN-A therapy rescue Ebola-infected nonhuman primates when administered after the detection of viremia and symptoms
-
207ra143
-
Qiu X, Wong G, Fernando L, et al. mAbs and Ad-vectored IFN-A therapy rescue Ebola-infected nonhuman primates when administered after the detection of viremia and symptoms. Sci. Transl. Med. 5(207), 207ra143 (2013
-
(2013)
Sci. Transl. Med
, vol.5
, Issue.207
-
-
Qiu, X.1
Wong, G.2
Fernando, L.3
-
38
-
-
84868149422
-
Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques
-
Olinger GG, Pettitt J, Kim D, et al. Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques. Proc. Natl Acad. Sci. USA 109(44), 18030-18035 (2012
-
(2012)
Proc. Natl Acad. Sci. USA
, vol.109
, Issue.44
, pp. 18030-18035
-
-
Olinger, G.G.1
Pettitt, J.2
Kim, D.3
-
39
-
-
84945217199
-
Mechanism of binding to Ebola virus glycoprotein by the ZMapp ZMAb and MB-003 cocktail antibodies
-
Davidson E, Bryan C, Fong RH, et al. Mechanism of binding to Ebola virus glycoprotein by the ZMapp, ZMAb, and MB-003 cocktail antibodies. J. Virol. 89 (21), 10982-10992 (2015
-
(2015)
J. Virol
, vol.89
, Issue.21
, pp. 10982-10992
-
-
Davidson, E.1
Bryan, C.2
Fong, R.H.3
-
40
-
-
84883864987
-
Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB- 003 monoclonal antibody cocktail
-
199ra113
-
Pettitt J, Zeitlin L, Kim DH, et al. Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB- 003 monoclonal antibody cocktail. Sci. Transl. Med. 5(199), 199ra113 (2013
-
(2013)
Sci. Transl. Med
, vol.5
, Issue.199
-
-
Pettitt, J.1
Zeitlin, L.2
Kim, D.H.3
-
41
-
-
84907263545
-
Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
-
Qiu X, Wong G, Audet J, et al. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature 514(7520), 47-53 (2014
-
(2014)
Nature
, vol.514
, Issue.7520
, pp. 47-53
-
-
Qiu, X.1
Wong, G.2
Audet, J.3
-
44
-
-
84912539210
-
Clinical care of two patients with Ebola virus disease in the United States
-
Lyon GM, Mehta AK, Varkey JB, et al. Clinical care of two patients with Ebola virus disease in the United States. N. Engl. J. Med. 371(25), 2402-2409 (2014
-
(2014)
N. Engl. J. Med
, vol.371
, Issue.25
, pp. 2402-2409
-
-
Lyon, G.M.1
Mehta, A.K.2
Varkey, J.B.3
-
45
-
-
84940467204
-
Clinical features and viral kinetics in a rapidly cured patient with Ebola virus disease: A case report
-
Schibler M, Vetter P, Cherpillod P, et al. Clinical features and viral kinetics in a rapidly cured patient with Ebola virus disease: a case report. Lancet Infect. Dis. 3099(15), 1-7 (2015
-
(2015)
Lancet Infect. Dis
, vol.3099
, Issue.15
, pp. 1-7
-
-
Schibler, M.1
Vetter, P.2
Cherpillod, P.3
-
46
-
-
84948807329
-
Ebola viral load at diagnosis associates with patient outcome and outbreak evolution
-
De La Vega MA, Caleo G, Audet J, et al. Ebola viral load at diagnosis associates with patient outcome and outbreak evolution. J. Clin. Invest. 125(12), 4421-4428 (2015
-
(2015)
J. Clin. Invest
, vol.125
, Issue.12
, pp. 4421-4428
-
-
De La Vega, M.A.1
Caleo, G.2
Audet, J.3
-
47
-
-
84991259720
-
Multi-national prevail II study team a randomized, controlled trial of zmapp for ebola virus infection
-
PREVAIL II Writing Group
-
PREVAIL II Writing Group, Multi-National PREVAIL II Study Team. A randomized, controlled trial of ZMapp for Ebola virus infection. N. Engl. J. Med. 375(15), 1448-1456 (2016
-
(2016)
N. Engl. J. Med
, vol.375
, Issue.15
, pp. 1448-1456
-
-
-
48
-
-
8344236780
-
Plant cell cultures for the production of recombinant proteins
-
Hellwig S, Drossard J, Twyman RM, Fischer R. Plant cell cultures for the production of recombinant proteins. Nat. Biotechnol. 22(11), 1415-1422 (2004
-
(2004)
Nat. Biotechnol
, vol.22
, Issue.11
, pp. 1415-1422
-
-
Hellwig, S.1
Drossard, J.2
Twyman, R.M.3
Fischer, R.4
-
49
-
-
84908521422
-
WHO gives go ahead for experimental treatments to be used in Ebola outbreak
-
Sayburn A. WHO gives go ahead for experimental treatments to be used in Ebola outbreak. BMJ 349, g5161 (2014
-
(2014)
BMJ
, vol.349
, pp. g5161
-
-
Sayburn, A.1
-
50
-
-
84923108405
-
Ebola drug trials lurch ahead
-
Kupferschmidt K, Cohen J. Ebola drug trials lurch ahead. Science 347(6223), 701-702 (2015
-
(2015)
Science
, vol.347
, Issue.6223
, pp. 701-702
-
-
Kupferschmidt, K.1
Cohen, J.2
-
51
-
-
84925581190
-
As Ebola epidemic begins to slow, trials of drugs and vaccines speed up
-
Kuehn BM. As Ebola epidemic begins to slow, trials of drugs and vaccines speed up. JAMA 313(10), 1000-1001 (2015
-
(2015)
JAMA
, vol.313
, Issue.10
, pp. 1000-1001
-
-
Kuehn, B.M.1
-
52
-
-
85006197840
-
Anti-Ebola therapies based on monoclonal antibodies: Current state and challenges ahead
-
González-González E, Alvarez MM, Márquez-Ipiña AR, et al. Anti-Ebola therapies based on monoclonal antibodies: current state and challenges ahead. Crit. Rev. Biotechnol. 37(1), 1-16 (2015
-
(2015)
Crit. Rev. Biotechnol
, vol.37
, Issue.1
, pp. 1-16
-
-
González-González, E.1
Alvarez, M.M.2
Márquez-Ipiña, A.R.3
-
53
-
-
84964425104
-
CHO cell production and sequence improvement in the 13C6FR1 anti-Ebola antibody
-
Pettit DK, Rogers RS, Arthur K, et al. CHO cell production and sequence improvement in the 13C6FR1 anti-Ebola antibody. MAbs 8(2), 347-357 (2016
-
(2016)
MAbs
, vol.8
, Issue.2
, pp. 347-357
-
-
Pettit, D.K.1
Rogers, R.S.2
Arthur, K.3
-
54
-
-
77953655955
-
Industrialization of mAb production technology: The bioprocessing industry at a crossroads
-
Kelley B. Industrialization of mAb production technology: the bioprocessing industry at a crossroads. MAbs 1(5), 443-452 (2009
-
(2009)
MAbs
, vol.1
, Issue.5
, pp. 443-452
-
-
Kelley, B.1
-
55
-
-
84960417838
-
Two-mAb cocktail protects macaques against the Makona variant of Ebola virus
-
329ra33
-
Qiu X, Audet J, Lv M, et al. Two-mAb cocktail protects macaques against the Makona variant of Ebola virus. Sci. Transl. Med. 8(329), 329ra33 (2016
-
(2016)
Sci. Transl. Med
, vol.8
, Issue.329
-
-
Qiu, X.1
Audet, J.2
Lv, M.3
-
56
-
-
84904596446
-
Specific polyclonal F(ab?)2 neutralize a large panel of highly pathogenic avian influenza A viruses (H5N1) and control infection in mice
-
Herbreteau CH, Jacquot F, Rith S, et al. Specific polyclonal F(ab?)2 neutralize a large panel of highly pathogenic avian influenza A viruses (H5N1) and control infection in mice. Immunotherapy 6(6), 699-708 (2014). www.futuremedicine. com/doi/10.2217/imt.14.40
-
(2014)
Immunotherapy
, vol.6
, Issue.6
, pp. 699-708
-
-
Herbreteau, C.H.1
Jacquot, F.2
Rith, S.3
-
57
-
-
84923254084
-
Safety, potential efficacy, and pharmacokinetics of specific polyclonal immunoglobulin F(ab?)2 fragments against avian influenza A (H5N1) in healthy volunteers: A single-centre, randomised, double-blind, placebo-controlled, Phase 1 study
-
Bal C, Herbreteau CH, Buchy P, et al. Safety, potential efficacy, and pharmacokinetics of specific polyclonal immunoglobulin F(ab?)2 fragments against avian influenza A (H5N1) in healthy volunteers: a single-centre, randomised, double-blind, placebo-controlled, Phase 1 study. Lancet Infect. Dis. 15(3), 285-292 (2015). http://linkinghub. elsevier.com/retrieve/pii/S1473309914710722
-
(2015)
Lancet Infect. Dis
, vol.15
, Issue.3
, pp. 285-292
-
-
Bal, C.1
Herbreteau, C.H.2
Buchy, P.3
-
58
-
-
84897432390
-
Triple immunoglobulin gene knockout transchromosomic cattle: Bovine lambda cluster deletion and its effect on fully human polyclonal antibody production
-
Matsushita H, Sano A, Wu H, et al. Triple immunoglobulin gene knockout transchromosomic cattle: bovine lambda cluster deletion and its effect on fully human polyclonal antibody production. PLoS ONE 9(3), e90383 (2014
-
(2014)
PLoS ONE
, vol.9
, Issue.3
, pp. e90383
-
-
Matsushita, H.1
Sano, A.2
Wu, H.3
-
59
-
-
84942826507
-
Emergence of Ebola virus escape variants in infected nonhuman primates treated with the MB-003 antibody cocktail
-
Kugelman JR, Kugelman-Tonos J, Ladner JT, et al. Emergence of Ebola virus escape variants in infected nonhuman primates treated with the MB-003 antibody cocktail. Cell Rep. 12(12), 2111-2120 (2015
-
(2015)
Cell Rep
, vol.12
, Issue.12
, pp. 2111-2120
-
-
Kugelman, J.R.1
Kugelman-Tonos, J.2
Ladner, J.T.3
-
60
-
-
84990963254
-
Preliminary evaluation of the effect of investigational Ebola virus disease treatments on viral genome sequences
-
Whitmer SLM, Albariño C, Shepard SS, et al. Preliminary evaluation of the effect of investigational Ebola virus disease treatments on viral genome sequences. J. Infect. Dis. 214(Suppl. 3), S333-S341 (2016
-
(2016)
J. Infect. Dis
, vol.214
, pp. S333-S341
-
-
Whitmer, S.L.M.1
Albariño, C.2
Shepard, S.S.3
-
61
-
-
84958078190
-
Discovery of an antibody for pan-Ebolavirus therapy
-
Furuyama W, Marzi A, Nanbo A, et al. Discovery of an antibody for pan-Ebolavirus therapy. Sci. Rep. 6, 20514 (2016
-
(2016)
Sci. Rep
, vol.6
, pp. 20514
-
-
Furuyama, W.1
Marzi, A.2
Nanbo, A.3
-
62
-
-
84953862148
-
Pan-Ebolavirus and Pan-filovirus mouse monoclonal antibodies: Protection against Ebola and Sudan viruses
-
Holtsberg FW, Shulenin S, Vu H, et al. Pan-Ebolavirus and Pan-filovirus mouse monoclonal antibodies: protection against Ebola and Sudan viruses. J. Virol. 90(1), 266-278 (2016
-
(2016)
J. Virol
, vol.90
, Issue.1
, pp. 266-278
-
-
Holtsberg, F.W.1
Shulenin, S.2
Vu, H.3
-
63
-
-
84934981152
-
Ebola virus epidemiology, transmission, and evolution during seven months in Sierra Leone
-
Park DJ, Dudas G, Wohl S, et al. Ebola virus epidemiology, transmission, and evolution during seven months in Sierra Leone. Cell 161(7), 1516-1526 (2015
-
(2015)
Cell
, vol.161
, Issue.7
, pp. 1516-1526
-
-
Park, D.J.1
Dudas, G.2
Wohl, S.3
-
64
-
-
84875648000
-
Novel mutations in Marburg virus glycoprotein associated with viral evasion from antibody mediated immune pressure
-
Kajihara M, Nakayama E, Marzi A, Igarashi M, Feldmann H, Takada A. Novel mutations in Marburg virus glycoprotein associated with viral evasion from antibody mediated immune pressure. J. Gen. Virol. 94(4), 876-883 (2013
-
(2013)
J. Gen. Virol
, vol.94
, Issue.4
, pp. 876-883
-
-
Kajihara, M.1
Nakayama, E.2
Marzi, A.3
Igarashi, M.4
Feldmann, H.5
Takada, A.6
-
65
-
-
84988696751
-
Trojan horse? Bispecific antibody strategy for broad protection against Ebolaviruses
-
Wec AZ, Nyakatura EK, Herbert AS, et al. A ?Trojan horse? bispecific antibody strategy for broad protection against Ebolaviruses. Science 354(6310), 350-354 (2016
-
(2016)
Science
, vol.354
, Issue.6310
, pp. 350-354
-
-
Wec, A.Z.1
Nyakatura, E.K.2
Herbert, A.S.3
|